Tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods.

The cleverer I am about miniaturizing the world, the better I am at possessing it.” That line of thinking, as practiced in nanoscale engineering, has no stronger embodiment today than ChemLex’s newly ...

ChemLex, a next-generation AI-for-science company, today announced the establishment of its global headquarters and ...

The most important asset within any digital economy revolves around data. The most successful companies are those whose ...

For decades, manufacturing research and d (R&D) has largely relied on a time-tested but costly model: trial and error. Scientists and engineers iterate through experiments, testing different material ...

Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...

Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...

Citi Annual Global Healthcare Conference 2025 December 3, 2025 11:15 AM ESTCompany ParticipantsMichael Bodner - Global Head ...

AI is going to disrupt the way professionals work. From marketers leveraging ChatGPT for producing content to developers ...

Discusses New Strategy and Business Plan Focused on Commercialization and Liquid Biopsy Innovation November 26, 2025 9:00 ...

Oxford Instruments launches Imaris 11, boosting research productivity with clear workflow-driven image analysis for ...

Imaris 11 supports the rapidly expanding life science and biotechnology ecosystems in Southeast Asia by enabling streamlined ...